Company Filing History:
Years Active: 2015-2017
Title: Innovations by Inventor Zachary Buchwald
Introduction
Zachary Buchwald is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biomedical research, particularly in the area of bone health. With a total of 2 patents, his work focuses on innovative methods to inhibit bone loss.
Latest Patents
Buchwald's latest patents include "Suppression of bone loss by introducing FoxP3+ CD8 T-cells (TcREG)" and "Systems and methods for inhibiting bone loss using FoxP3+ CD8 T-cells (Tc)." In these patents, he explores how osteoclasts can be induced to produce FoxP3+ CD8 T-cells (Tc) through the introduction of a low dose of a RANK agonist, such as RANKL. His research indicates that RANKL is most effective when administered in a pulsed schedule. Additionally, he describes methods for providing FoxP3+ CD8 T-cells (Tc) to patients to regulate osteoclast function, establishing a bi-directional regulatory loop between these cells.
Career Highlights
Zachary Buchwald is affiliated with Saint Louis University, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential impact on treating conditions related to bone loss.
Collaborations
Buchwald collaborates with esteemed colleagues, including Rajeev Aurora and Jennifer Kiesel, to advance his research and explore new avenues in the field.
Conclusion
Zachary Buchwald's contributions to the field of bone health through his innovative patents highlight his role as a leading inventor. His research has the potential to significantly impact the treatment of bone loss, showcasing the importance of innovation in biomedical science.